ESMO 2014

Oncology Meeting Resources

26 Sep - 30 Sep 2014, Madrid, Spain

ESMO 2014 Congress

The theme for ESMO 2014 was ‘Precision Medicine in Cancer Care.’ Whether you are a medical or surgical oncologist or a radiation oncologist, immunologist or pathologist, practising precision medicine means we are all working towards a common goal – improved patient outcomes. For your convenience and due to the large quantity of information coming from the ESMO 2014 congress, we have split the presentations up by main congress topic to allow you to find the information you need more easily.

Here, you will find the abstracts, posters, PDF presentation and webcasts from ESMO 2014 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Drug Index of ESMO 2014 Abstracts

Special Sessions and Tracks

Useful links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...rgeting-the-androgen-axis-in-prostate-cancer

Date: 26 Sep 2014
Presenter: Gerhardt Attard
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...-discussion-When-to-start-treatment-in-mCRPC

Date: 26 Sep 2014
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...-drive-the-appropriate-sequencing-of-therapy

Date: 26 Sep 2014
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...-Satellite-Sessions/Welcome-and-introduction

Date: 26 Sep 2014
Presenter: Joan Carles
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...ic-castration-resistant-prostate-cancer-CRPC

Date: 26 Sep 2014
Presenter: Cora Sternberg
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...Satellite-Sessions/Sequencing-considerations

Date: 26 Sep 2014
Presenter: Eleni Efstathiou
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...nical-trial-data-for-daily-clinical-practice

Date: 26 Sep 2014
Presenter: Maria De Santis
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...ndustry-Satellite-Sessions/Summary-and-close

Date: 26 Sep 2014
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...er-and-visceral-disease-in-the-PREVAIL-trial

AimIn the PREVAIL trial, enzalutamide, an androgen receptor signaling inhibitor, significantly improved overall survival (OS) (HR, 071; p < 0.0001) and radiographic progression- free survival (rPFS) (HR, 0.

Date: 27 Sep 2014
Presenter: Celestia Higano
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...bone-metastases-mets-from-the-ALSYMPCA-trial

AimBone mets in CRPC frequently cause symptomatic skeletal events (SSEs) requiring EBRT for pain. In ALSYMPCA, Ra, a first-in-class α-emitter, improved overall survival and delayed time to first SSE (Parker NEJM 2013).

Date: 27 Sep 2014
Presenter: Joe O'Sullivan
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Supportive Care, Prostate Cancer, Surgery and/or Radiotherapy of Cancer